Discoidin domain receptor 1 (DDR1) appears a potential candidate for collagen binding, which has recently been associated with malignancy, metastasis, and resistance in other tumor entities, such as breast cancer [32], gastric cancer [33], or pancreatic ductal adenocarcinomas [34]. This evidence concerns the gene DDR1 and breast carcinoma.